Delibası T - Search Results

1

Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism.

Karbek B, Özbek M, Bozkurt NC, Ginis Z, Güngünes A, Ünsal IÖ, Cakal E, Delibası T. Karbek B, et al. Among authors: delibasi t. Cardiovasc Diabetol. 2011 May 2;10:37. doi: 10.1186/1475-2840-10-37. Cardiovasc Diabetol. 2011. PMID: 21535886 Free PMC article.

2

Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.

Karbek B, Cakal E, Cakir E, Bozkurt N, Unsal I, Sahin M, Delibaşi T. Karbek B, et al. Among authors: delibasi t. Minerva Endocrinol. 2013 Sep;38(3):297-304. Minerva Endocrinol. 2013. PMID: 24126550

3

Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.

Karbek B, Bozkurt NC, Topaloglu O, Aslan MS, Gungunes A, Cakal E, Delibasi T. Karbek B, et al. Among authors: delibasi t. Minerva Endocrinol. 2014 Jun;39(2):99-105. Minerva Endocrinol. 2014. PMID: 24736484

4

Preclinical atherosclerosis in patients with prolactinoma.

Arslan MS, Topaloglu O, Sahin M, Tutal E, Gungunes A, Cakir E, Ozturk IU, Karbek B, Ucan B, Ginis Z, Cakal E, Ozbek M, Delibasi T. Arslan MS, et al. Among authors: delibasi t. Endocr Pract. 2014 May;20(5):447-51. doi: 10.4158/EP13173.OR. Endocr Pract. 2014. PMID: 24325995

5

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.

Karbek B, Ozbek M, Karakose M, Topaloglu O, Bozkurt NC, Cakır E, Aslan MS, Delibasi T. Karbek B, et al. Among authors: delibasi t. J Ovarian Res. 2014 Mar 14;7:31. doi: 10.1186/1757-2215-7-31. J Ovarian Res. 2014. PMID: 24628831 Free PMC article.

6

Serum heart type fatty acid binding protein levels are not changed in hyperthyroidism.

Ozbek M, Gungunes A, Sahin M, Ginis Z, Ucan B, Sayki M, Tutal E, Cakal E, Kuşkonmaz SM, Öztürk MA, Delibasi T. Ozbek M, et al. Among authors: delibasi t. Minerva Endocrinol. 2016 Sep;41(3):298-301. Epub 2016 Feb 9. Minerva Endocrinol. 2016. PMID: 26859315

7

Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.

Cakir E, Ozbek M, Ozkaya E, Colak N, Cakal E, Sayki M, Gungunes A, Aliyazicioglu Y, Mentese A, Delibasi T. Cakir E, et al. Among authors: delibasi t. J Endocrinol Invest. 2011 Jul-Aug;34(7):e178-82. doi: 10.3275/7352. Epub 2010 Nov 16. J Endocrinol Invest. 2011. PMID: 21088474

8

The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities.

Bozkurt NC, Cakal E, Sahin M, Ozkaya EC, Firat H, Delibasi T. Bozkurt NC, et al. Among authors: delibasi t. Endocrine. 2012 Jun;41(3):518-25. doi: 10.1007/s12020-012-9595-1. Epub 2012 Jan 14. Endocrine. 2012. PMID: 22246808

9

Is NAFLD an independent risk factor for increased IMT in T2DM?

Cakır E, Ozbek M, Colak N, Cakal E, Delıbaşi T. Cakır E, et al. Among authors: delibasi t. Minerva Endocrinol. 2012 Jun;37(2):187-93. Minerva Endocrinol. 2012. PMID: 22691891

10

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.

Gungunes A, Ozbek M, Ginis Z, Sahin M, Demirci T, Cakir Ozkaya E, Karbek B, Sayki Arslan M, Ozturk Unsal I, Tutal Akkaya E, Ucan B, Gultuna Ozguclu S, Cakal E, Topaloglu O, Delibasi T. Gungunes A, et al. Among authors: delibasi t. Minerva Endocrinol. 2014 Sep;39(3):209-14. Minerva Endocrinol. 2014. PMID: 25068306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters